Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort study.

[1]  Szu-Yuan Wu,et al.  Effect of opioids on cancer survival in patients with chronic pain: a propensity score-matched population-based cohort study. , 2022, British journal of anaesthesia.

[2]  David R. Jones,et al.  Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis. , 2021, British journal of anaesthesia.

[3]  David R. Jones,et al.  Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma. , 2021, British journal of anaesthesia.

[4]  P. Marchetti,et al.  The role of opioids in cancer response to immunotherapy , 2021, Journal of translational medicine.

[5]  W. Chapman,et al.  Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer. , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Joseph R. Scarpa,et al.  Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and Survival , 2020, Cancer Research.

[7]  Joseph R. Scarpa,et al.  Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer. , 2020, British journal of anaesthesia.

[8]  Joseph R. Scarpa,et al.  Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia. , 2020, British journal of anaesthesia.

[9]  T. Smyrk,et al.  Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance). , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  P. Sacerdote,et al.  Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies , 2019, Front. Immunol..

[11]  D. Ma,et al.  Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. , 2019, British journal of anaesthesia.

[12]  Qin Li,et al.  Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy , 2019, Journal of Hematology & Oncology.

[13]  Denis Torre,et al.  Geneshot: search engine for ranking genes from arbitrary text queries , 2019, Nucleic Acids Res..

[14]  GuoLin Wang,et al.  Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo , 2018, Anesthesiology.

[15]  W. Hofstetter,et al.  Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma , 2018, Anesthesia and analgesia.

[16]  E. Sloan,et al.  Perioperative events influence cancer recurrence risk after surgery , 2018, Nature Reviews Clinical Oncology.

[17]  S. Ben-Eliyahu,et al.  Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers , 2018, British journal of anaesthesia.

[18]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[19]  J. Cata,et al.  Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. , 2015, Journal of clinical anesthesia.

[20]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[21]  K. Kinzler,et al.  The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints , 2015, Journal of Immunotherapy for Cancer.

[22]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[23]  P. White,et al.  Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis. , 2014, British journal of anaesthesia.

[24]  J. Cata,et al.  A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection , 2014, Cancer medicine.

[25]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[26]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[27]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[28]  J. Galon,et al.  Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. , 2011, Cancer research.

[29]  S. Gruber,et al.  Microsatellite instability in colorectal cancer—the stable evidence , 2010, Nature Reviews Clinical Oncology.

[30]  R. Houlston,et al.  Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[32]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.